{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-000990","form_type":"8-K","ticker":"EYPT","cik":"0001314102","company_name":"EyePoint, Inc.","filed_at":"2023-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.348806+00:00","generated_at":"2026-06-20T11:34:28.260739+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"EyePoint signs lease for 40,000 sq ft manufacturing facility; rent starts H2 2024","bullets":["Lease for build-to-suit cGMP facility in Northbridge, MA to support EYP-1901 and YUTIQ manufacturing.","Annual base rent ~$2.44M ($61/sq ft), escalating to ~$3M over 15-year initial term; total ~$41M.","Rent commences in H2 2024 after construction; facility expected operational in H2 2024.","Awarded $1.9M in state and local tax incentives as part of the agreement.","Two renewal options (5 or 10 years) at 95% of fair market rent; expansion right up to 20,000 sq ft."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-000990","json":"https://secwatch.observer/filing/0000950170-23-000990.json","markdown":"https://secwatch.observer/filing/0000950170-23-000990.md","text":"https://secwatch.observer/filing/0000950170-23-000990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314102/000095017023000990/0000950170-23-000990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314102/000095017023000990/eypt-20230123.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T11:34:28.260739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b5ff46e48b4a4aed7487b87962dc57373f9be086","claim":"EyePoint, Inc. entered into Lease with V.E. Properties IX, LLC valued at approximately $41 million (effective 2023-01-23).","evidence_excerpt":"On January 23, 2023, EyePoint Pharmaceuticals, Inc. (the “Company”) and V.E. Properties IX, LLC (the “Landlord”) entered into a lease agreement (the “Lease”) relating to the lease by the Company of a to-be-constructed build-to-suit stand-alone commercial manufacturing facility","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1314102/000095017023000990/0000950170-23-000990-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"lease"},{"label":"Counterparty","value":"V.E. Properties IX, LLC"},{"label":"Value","value":"approximately $41 million"},{"label":"Effective","value":"2023-01-23"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}